Filing Flows › Xwell (XWEL) › Q2 2026 › vs Q2 2025
Xwell (XWEL) Q2 2026 vs Q2 2025 (year over year)
Xwell's revenue fell $544K (-7%) from $7.7M in Q2 2025 to $7.1M in Q2 2026. The biggest changes: XpresSpa −$715K (-15%); XpresTest +$315K (+15%); Naples Wax −$144K (-22%).
Xwell, Q2 2026: revenue $7.1M (-7% year over year), operating margin -29.4%, net loss $1.9M, operating cash flow −$4.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| XpresSpa | $4.2M | $4.9M | −$715K | -15% |
| XpresTest | $2.5M | $2.2M | $315K | +15% |
| Naples Wax | $503K | $647K | −$144K | -22% |
| Revenue | $7.1M | $7.7M | −$544K | -7% |
| Other income, net | $272K | $674K | −$402K | -60% |
| Net loss | $1.9M | $2.1M | −$169K | -8% |
| Costs & expenses | $9.3M | $10.4M | −$1.1M | -11% |
| Operating costs | $9.2M | $10.4M | −$1.1M | -11% |
| Income tax | $51K | $34K | $17K | +50% |
| Cost of revenue | $4.2M | $5.9M | −$1.7M | -29% |
| SG&A | $4.7M | $4.3M | $370K | +9% |
| Other operating costs | $402K | $187K | $215K | +115% |
| Operating cash sources | $4.8M | $3.2M | $1.6M | +51% |
| Depreciation & amortization | $163K | $187K | −$24K | -13% |
| Share-based compensation | $98K | $599K | −$501K | -84% |
| Cash used in operations | $4.5M | $2.4M | $2.1M | +89% |
| Net loss absorbed | $1.9M | $2.1M | −$169K | -8% |
| Working capital & other | $2.9M | $1.1M | $1.8M | +158% |
Questions
How much did Xwell's revenue grow year over year in Q2 2026?
Xwell's revenue fell $544K (-7%) from $7.7M in Q2 2025 to $7.1M in Q2 2026.
What drove Xwell's revenue change in Q2 2026?
XpresSpa −$715K (-15%); XpresTest +$315K (+15%); Naples Wax −$144K (-22%).